Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
MicroRNA
100%
International System
66%
Chronic Lymphocytic Leukemia
55%
Cytogenetic Nomenclature
52%
Human Cytogenetics
50%
Electronic Health Records
49%
Clinical Data
49%
In Cancer
45%
Karyotype Analysis
41%
Mercator
38%
Metastatic Melanoma
38%
Single-cell RNA Sequencing (scRNA-seq)
36%
Plasma microRNA
36%
Cancer Types
35%
Transcription Factor
34%
Clonal Heterogeneity
33%
SNP Array
33%
Whole Genome Sequencing
33%
Resection
33%
Distance Metric
33%
Mixed Data
33%
Bioinformatics
33%
MicroRNA Profiling
33%
Patient Plasma
33%
Large Language Models
33%
Genetic Data
32%
Overall Survival
29%
Unsupervised Machine Learning
28%
Generative Transformer
26%
Postsurgical
26%
Human Brain
25%
Computational Analysis
25%
Clinical Trials
25%
Publicly Available
25%
Prediction Task
25%
Pattern Recognition
24%
Gene Expression
24%
Threshing
22%
Disease Progression
22%
Cellular Level
22%
Silhouette Width
22%
Plasma Samples
22%
Melanoma
21%
Transcriptome
21%
Machine Learning Techniques
20%
Surgical Resection
19%
Pre-surgical
19%
Adjusted Rand Index
19%
Continuous Data
19%
MicroRNA Profile
19%
Medicine and Dentistry
Metastatic Melanoma
50%
microRNA
50%
Melanoma
35%
Diseases
34%
Karyotype
33%
Pattern Recognition
33%
B-Cell Chronic Lymphocytic Leukemia
33%
Electronic Health Record
25%
Cell Line
22%
Tumor Cell
16%
Folate Receptor
16%
Pancreas Adenocarcinoma
16%
Weakness
16%
Socioeconomic Status
16%
Immunoglobulin
16%
Folic Acid
16%
Natural Killer Cell
16%
Prognostic Factor
16%
Human Cytomegalovirus
16%
Glioblastoma
16%
Myeloid-Derived Suppressor Cell
16%
Rituximab
16%
Chemoimmunotherapy
16%
Fludarabine
16%
Cyclophosphamide
16%
Predictive Modeling
16%
Neurofibromatosis Type I
16%
Comorbidity
16%
Portal Hypertension
16%
Liver Graft
16%
Transjugular Intrahepatic Portosystemic Shunt
16%
Shunt Creation
16%
Tumor
16%
Overall Survival
13%
Cytokine
12%
Logistic Regression Analysis
12%
Survival Analysis
12%
Neoplasm
12%
Multidimensional Scaling
11%
Immunoglobulin Heavy Chain
11%
Hematologic Malignancy
11%
Student T Test
10%
Proportional Hazards Model
9%
IGHV@
9%
Cross Sectional Study
8%
Alzheimer's Disease
8%
Combination Therapy
8%
Treatment of Alzheimer's Disease
8%
Health Disparity
8%
Odds Ratio
8%
